HIT Consultant – Read More

Pharma medical affairs teams have spent the last decade investing heavily in digital transformation. Virtual advisory boards, omnichannel platforms, CRM systems, and analytics dashboards are now standard. Yet despite this progress, many medical engagement strategies still appear static. Plans are often locked in annually, channels are treated as separate silos, and success is measured by activity rather than relevance.

The disconnect is not a lack of data or tools. It is that engagement models have not kept pace with how healthcare professionals actually consume scientific information today. In a world where clinicians move fluidly between formats, timelines, and levels of depth, static engagement plans struggle to remain useful. Decision engines help bridge that gap by shifting medical affairs from rigid execution to adaptive, insight-guided engagement that respects both scientific integrity and regulatory boundaries.

Why static engagement no longer reflects how HCPs learn

Medical affairs planning has traditionally mirrored clinical trial thinking. You define objectives, map audiences, select channels, and execute against a fixed plan. This approach works well in controlled environments. It works far less well in the reality of modern clinical practice.

Today, a single healthcare professional may skim a congress highlight on a mobile device between patients, attend a virtual symposium weeks later, download a publication when a complex case arises, and engage with an MSL months after that. Their needs change based on specialty, patient mix, time pressure, and evolving evidence. Static engagement models assume predictability where there is none.

This is akin to prescribing the same treatment plan for every patient, regardless of symptoms or disease progression. In medicine, personalization is non-negotiable. In medical engagement, it remains aspirational.

Let us take spectrum allocation as an example. Spectrum allocation illustrates the difference between static and adaptive decision-making. Fixed assignments can work in stable conditions, but interference, demand spikes, or new devices quickly create problems. Modern systems dynamically adjust frequencies within regulatory guardrails, shifting usage where needed while preventing conflicts. Adaptive frameworks balance flexibility and control, maintaining reliability and trust even in complex, changing environments

When engagement plans are fixed and channel-specific, teams risk either overcommunicating or missing the moment when information is most valuable. Scientific exchange becomes transactional rather than contextual. The result is frustration on both sides, with medical teams executing plans that feel compliant but not necessarily helpful.

Decision engines as navigational systems, not automation shortcuts
 

Decision engines are often misunderstood as tools that automate engagement or replace human judgment. In medical affairs, their real value lies elsewhere. They function more like navigational systems than autopilots.

A navigation app does not decide where you should go. It helps you choose the best route based on traffic, timing, and constraints. Similarly, a decision engine can help medical teams determine when engagement is appropriate, which content is relevant, and which channel aligns with the current context, while leaving final judgment to medical professionals.

Rather than pre-assigning fixed touchpoints, decision engines synthesize signals such as prior interactions, content consumption patterns, specialty-specific behaviors, and external events like congresses or guideline updates. This allows teams to respond to real-world behavior rather than forcing behavior into predefined plans.

Importantly, this does not mean chasing every signal. In regulated environments, restraint matters as much as responsiveness. A well-designed decision engine operates within guardrails that reflect compliance rules, scientific standards, and approved content. It guides choices, it does not improvise them.

A useful analogy is how traffic management or mobility systems operate in the real world. Traffic moves unconstrained. Clear rules and considerations are applied in regulating traffic and managing congestion through signals, lanes, and speed limits that balance traffic flow with predictability.

By shifting the focus from channel execution to decision quality, medical affairs teams can support scientific exchange that feels timely and relevant without crossing regulatory lines. Engagement becomes less about volume and more about appropriateness.

What pharma leaders need to make adaptive engagement work

Moving from static plans to intelligent engagement is not primarily a technology challenge. It is an organizational one. Decision engines only work when certain capabilities are in place.

First, data must be connected across touchpoints. Fragmented systems lead to fragmented decisions. Leaders need to prioritize interoperability and shared definitions of engagement success, not just more dashboards.

Second, governance models must evolve. Adaptive engagement requires clarity on what decisions can be guided by algorithms and which require human oversight. Medical, legal, and compliance teams need to be involved early, not as gatekeepers at the end.

Third, medical teams need confidence and training. Decision engines should empower MSLs and medical leaders, not constrain them. This means investing in change management and reinforcing that professional judgment remains central.

Finally, leadership must accept that adaptive engagement looks messier than static plans. Outcomes may be harder to predict, but they are often more meaningful. Just as personalized medicine embraces variability to improve patient outcomes, intelligent medical engagement embraces flexibility to improve scientific exchange.

As digital transformation matures, the question is no longer whether pharma has the tools to engage differently. It is whether medical affairs organizations are willing to rethink how decisions are made. Decision engines offer a path forward not by automating science but by enabling smarter, more human engagement in an increasingly complex information landscape.

About Jones Jaick

Jones Jaick leads global medical digital and omnichannel transformation initiatives, helping life sciences organizations improve their engagement through strategy, technology, and analytics. A Partner at ZS Associates, he works across medical engagement, decision engines, omnichannel strategy, and customer data foundations. He has partnered with medical affairs teams across the US and international markets and has spoken at industry events including MAPS, DIA MASC, and Reuters.